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ABSTRACT 
Chikungunya virus (CHIKV), a re-emerging infectious arbovirus, causes Chikungunya fever that is characterized 
by fever, skin rash, joint pain, arthralgia and occasionally death. Despite it has been described for 66 years already, 
neither potential vaccine nor a specific drug is available yet. During CHIKV infection, interferon type I signaling 
pathway is stimulated and releases hundreds of interferon stimulated genes (ISGs). Our previous study reported 
that IFI16, a member of ISGs, is up-regulated during CHIKV virus infection and the suppression of the gene 
resulted in increased virus replication. Furthermore, our group also found that inflammasome activation can inhibit 
CHIKV infection in human foreskin cells (HFF1). Concomitantly, it has been reported that IFI16 activates the 
inflammasome to suppress virus infection. Therefore, we have hypothesized that IFI16 could be involved in 
CHIKV infection. In this study, we confirmed the expression level of IFI16 by Western blotting analysis and found 
that IFI16 was up-regulated following CHIKV infection in both HFF1 and human embryonic kidney cells. We 
next investigated its antiviral activity and found that forced expression of IFI16 completely restricted CHIKV 
infection while endogenous silencing of the gene markedly increased virus replication. Furthermore, we have dis-
covered that IFI16 inhibited CHIKV replication, at least, in cell-to-cell transmission as well as the diffusion step. 
Interestingly, IFI16 also exerted its antiviral activity against Zika virus (ZIKV) infection, the global threat re-
emerging virus can cause microcephaly in humans. Taken together, this study provides the first evidence of an 
antivirus activity of IFI16 during in vitro arbovirus infection, thus expanding its antiviral spectrum that paves the 
way to further development of antiviral drugs and vaccines.  
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INTRODUCTION 
Chikungunya virus (CHIKV) is an emerg-
ing infectious virus belonging to the family 
Togaviridae, genus alphavirus. CHIKV was 
named Makonde “kungunyala” which means 
“that which bends up”, referring to the posture 
of patients suffering from severe joint pain 
during CHIKV infection, after it was first re-
ported in Makonde plateau (Southern Tanza-
nia) in 1952 (Robinson, 1955). The virus can 
be transmitted by the bite of mosquito vectors 
including Aedes (Ae.) aegypti and Ae. Al-
bopictus which occurrs initially in human 
skin. Due to the huge expansion of mosquito 
vectors the prevalence of CHIKV now 
spreads approximate 60 countries throughout 
tropical and sub-tropical areas in the world 
(Wahid et al., 2017). CHIKV infection in hu-
mans causes Chikungunya fever (CHIKF) 
which is a febrile associated with high fever, 
rash, headache and can be a chronic condition 
that lasts for years (Hamer, 2019). The in-
creasing emergence of CHIKV urgently 
needs a specific treatment to minimize the 
symptoms and morbidity. Until now, owing to 
the absence of vaccine against CHIKV infec-
tion or its treatment, extensive research ef-
forts have been directed towards the develop-
ment of suitable antiviral strategies.  
During CHIKV infections, type I interfer-
ons (IFNs) are known to be produced and to 
initiate the production of pro-inflammatory 
cytokines. Interferon stimulated genes (ISGs) 
against the virus infection are triggered (Lum 
and Ng, 2015). Understandably, our previous 
study reported that inhibition of IFN type I 
signaling pathway leads to the enhancement 
of CHIKV replication (Wichit et al., 2017a). 
Interestingly, in a similar study, interferon-in-
ducible protein 16 (IFI16) expression level 
markedly decreases while an increase of virus 
was observed. 
IFI16 is a member of the PYHIN protein 
family (also known as p200 or HIN-200 pro-
teins) composed of a Pyrin domain, a protein-
protein interaction site, and two HIN domains 
(HinA and HinB), a non-specific dsDNA 
binding domain (Unterholzner et al., 2010; Jin 
et al., 2012). Previous studies have reported 
that IFI16 can activate innate antiviral im-
mune responses by acting as a nuclear patho-
gen sensor to induce the inflammasome 
(Kerur et al., 2011) or trigger the STING-
TBK1-IRF3 of IFN I signaling pathway 
(Orzalli et al., 2012, 2015; Li et al., 2013; 
Thompson et al., 2014) in order to inhibit Her-
pes simplex virus (HSV), Human cytomegal-
ovirus (HCMV) as well as Sendai virus 
(SeV). Moreover, IFI16 was also described as 
a viral restriction vector against ICP0-null 
HSV-1 and HCMV in both fibroblasts and 
keratinocytes (Gariano et al., 2012; Orzalli et 
al., 2013; Johnson et al., 2018; Merkl et al., 
2018) and human papillomavirus 18 (HPV18) 
in U2OS cells (Lo Cigno et al., 2015). Re-
cently, Merkl and Knipe explained the IFI16 
restriction role. As a matter of fact, they 
reported that IFI16 can recruit the other re-
striction factors such as the promyelocytic 
leukemia (PML), Sp100 and ATRX to form 
nuclear filamentous structures named “re-
strictosome” which signals in cis and trans to 
suppress the progeny viral DNA (Merkl and 
Knipe, 2019). Although, there are many re-
ports describing an antiviral function of 
IFI16, there is no evidence of its role in 
CHIKV infection which is the global threat 
arbovirus. 
As, IFI16 is involved in the inflam-
masome activation via the induction of 
caspase-1 and IL-1β, this results in the regu-
lation of herpesvirus KSHV (Merkl et al., 
2018). Concomitantly, our previous study has 
reported the responsiveness of IFI16 expres-
sion level during CHIKV infection (Wichit et 
al., 2016). Moreover, we described the antivi-
ral activity involvement of the inflammasome 
in the main route of transmission via human 
foreskin cells (Ekchariyawat et al., 2015). 
Thus, we hypothesized that IFI16 should be 
implicated on CHIKV replication. In this 
study, we investigated the antiviral activity of 
IFI16 in CHIKV replication on HFF1. We 
found that intrinsic IFI16 expression level 
was up-regulated during CHIKV infection in 
human skin cells and epithelial from human 
embryonic kidney cells. Interestingly, over-
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expression of IFI16 suppressed CHIKV infec-
tion while its knockdown clearly enhanced 
the viral replication in human skin fibroblasts. 
 
MATERIALS AND METHODS 
Cells and virus 
C6/36 Ae. albopictus cells, used for prop-
agation of the CHIKV strains, were grown at 
28 °C in Dulbecco’s modified Eagle’s me-
dium (DMEM; Invitrogen) supplemented 
with 10 % fetal calf serum (FCS; Lonza) as 
previously described (Wichit et al., 2017b). 
The HFF1 human skin fibroblast cell line, 
Vero cells (African green monkey cell line) 
and HEK293T (Human embryonic kidney 
cell line) were maintained in DMEM supple-
mented with 15 %, 5 % and 10 % FCS, re-
spectively (Wichit et al., 2017b). All cell lines 
were purchased from ATCC. 
The low-passage-number of the CHIKV 
LR2006_OPY1 strain (Wichit et al., 2017b), 
was isolated from a viremic patient in La Ré-
union Island in 2006. The clinical isolate PF-
25013-18 of ZIKV has been previously de-
scribed (Hamel et al., 2015). All viruses were 
grown in C6/36 cells at 28 °C and kept 
at -80 °C until used. 
 
Antibodies, reagents and plasmid 
Rabbit monoclonal anti-IFI16 antibody 
was purchased from Santa Cruz Biotechnol-
ogy, mouse monoclonal anti-β–actin anti-
body, anti-rabbit IgG HRP conjugated anti-
body, anti-Mouse IgG HRP conjugated anti-
body, thiazolyl blue tetrazolium bromide 
(MTT) were purchased from Sigma-Aldrich 
(St Louis, MO). The IFI16-FL-encoding 
cDNA cloned in the pcDNA3-FLAG expres-
sion plasmid was obtained from Addgene 
(#35064). Lipofectamine 2000 was purchased 
from Invitrogen. 
 
Viability assay 
Cell viability was determined using a 
MTT-based assay. Briefly, cells were trans-
fected with the IFI16 plasmid and incubated 
at 37 °C, 5 % CO2 for 24 hours (h), washed by 
phosphate-buffered saline (PBS) and then in-
cubated with 100 µL MTT. After 2 h, MTT 
was removed and 50 µL of DMSO was added 
to each well and mixed thoroughly. The mix-
ture was incubated at 37 °C for 10 min and 
cellular viability was determined by measur-
ing the absorbance value at 570 nm. 
 
Viral infection 
Human fibroblasts were seeded in six-
well plates and grown to 70–80 % confluence. 
The cultures were rinsed twice with PBS and 
the cells were incubated with CHIKV or 
ZIKV at the desired multiple of infection 
(MOI) for 2 h at 37 °C while gently agitating 
the plates. Then, the inoculum was removed 
and the cells were washed three times with 
PBS. DMEM supplemented with 15 % FCS 
was added to each well and the plates were 
incubated at 37 °C and 5 % CO2, for the dura-
tion of the experiment. Cells serving as a neg-
ative control were incubated with culture su-
pernatant from uninfected C6/36 cells. 
 
Transfection 
Human skin fibroblasts cells were seeded 
in six-well plates. After a 24 h incubation at 
37 °C with 5 % CO2, plasmids were trans-
fected with Lipofectamine 2000 according to 
the manufacturer’s protocol. The transgenes 
expression were evaluated by Western blot 
analysis and RT-qPCR. 
 
Plaque assay 
Vero cells, grown to 70–80 % confluence, 
were incubated with four separate, ten-fold, 
dilutions of viral supernatant in DMEM at 
37 °C for 2 h. Then, a mix of nutriment solu-
tion with agar (Lonza) was added and the cells 
were maintained at 37 °C for 5 days. For 
plaque counting, the cells were incubated 
with 3.7 % formaldehyde and 0.5 % Crystal 
violet in 20 % ethanol. 
 
Western blotting analysis 
Cells were lysed on ice in RIPA buffer 
(150 mM NaCl, 5 mM β-mercaptoethanol, 
1 % NP-40, 0.1 % sodium dodecyl sulfate, 
50 mM Tris-HCl, pH 8) supplemented with 
protease inhibitor cocktail solution (Sigma-
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Aldrich). The protein concentration was de-
termined by bicinchoninic acid (BCA) assay 
(Thermo Scientific). Equal amounts of pro-
teins were mixed with Laemmli sample load-
ing buffer, heated for 5 min at 100 °C, sub-
jected to SDS-PAGE and electrotransferred 
onto a nitrocellulose membrane. The mem-
brane was blocked with 0.05 % Tween 20 in 
PBS (PBST) containing 5 % skim milk for 1 h 
at room temperature (RT), then incubated 
overnight at 4 °C with the desired primary an-
tibody. Membranes were then washed three 
times with PBST, and subsequently incubated 
for 1 h at RT with horseradish peroxidase-
coupled secondary antibodies (Cell Signal-
ing) in PBST. The membrane was washed 
three times, and proteins were detected by 
chemiluminescence using a SuperSignal 
West Pico chemiluminescent substrate kit 
(Thermo Scientific). The membrane was then 
stripped and re-probed with an anti-β-actin 
antibody to ensure that equivalent levels of 
protein were loaded in each lane. 
 
Gene expression by real-time PCR analysis 
Total RNA was extracted from fibroblasts 
using Tri reagent (Sigma-Aldrich) following 
the manufacturer’s protocol. cDNA was syn-
thesized using 0.5 μg of total RNA and the 
MMLV reverse transcription Kit (Promega). 
The expressions of genes were quantified by 
RT-qPCR using the Roche Light Cycler 
LC480 device and specific primers (Table 1). 
All data are presented as mean ± SD. A com-
parison of real-time PCR values was made 
with the student T-test. For all experiments, 
statistical significance was accepted at p < 
0.05. 
 
Viral RNA quantification by real-time  
RT-PCR 
Total RNA was extracted from human fi-
broblasts by using Tri reagent (Sigma-Al-
drich). The RNA pellet was resuspended in 
25 μl of RNase-free distilled water and stored 
at -80 °C. The RNA was then used for reverse 
transcription using MMLV reverse transcrip-
tion Kit (Promega) according to the manufac-
turer’s instructions. The reaction was carried 
out using 1 μg total RNA as template for the 
normalization of viral RNA to the amount of 
total RNA. The MaximaTM Probe/ROX 
qPCR Master Mix (2x) (Thermo Scientific) 
was used in qPCR experiments. Each reaction 
of 25 μL contained 400 nM of each primer, 
200 nM of specific probe and 1x Maxima 
Probe/ROX qPCR Master Mix.  
Primers and probe sequences are listed in 
Table 1. The amplification conditions were 
95 °C for 10 min followed by 45 amplifica-
tion cycles of 95 °C for 15 s, 60 °C for 20 s 
and 72 °C for 30 s. The reactions were per-
formed in an Applied Biosystem 7300 sys-
tem. Real-time data were analyzed using the 
SDS software (Thermo Fisher Scientific). Vi-
ral RNA was quantified by comparing the 
sample’s threshold cycle (Ct) values with 
each virus RNA standard curve which was 
obtained as previously described (Wichit et 
al., 2017b). 
 
Table 1: Primers and probes sequences used in this study 
Target Primer Sequence (5’3’) 
CHIKV 
CHIKV- forward 5’AAGCT(CT)CGCGTCCTTTACCAAG3’ 
CHIKV- reverse 5’CCAAATTGTCC(CT)GGTCTTCCT3’ 
CHIKV-probe 5’CCAATGTC(TC)TC(AC)GCCTGGACACCT3’ 
ZIKV 
ZIKV- forward 5’TTGGTCATGATACTGCTGATTGC3’ 
ZIKV - reverse 5’CCTTCCACAAAGTCCCTATTGC3’ 
ZIKV - probe 5’CGGCATACAGCATCAGGTGCATAGGAG3’ 
IFI16 
IFI16- forward 5’CCCAAAGAAGATCATTGCCATAG3’ 
IFI16- reverse 5’GTTTCGGTCAGCATTCACATC3’ 
GAPDH 
GAPDH- forward 5’TCGGAGTCAACGGATTTGGT3’ 
GAPDH- reverse 5’TCGCCCCACTTGA TTTTGGA3’ 
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Data analysis and statistical methods 
All data are presented as means ± SD. A 
comparison of qPCR values was made with 
the student T-test. For all experiments, statis-
tical significance was accepted at p < 0.05. 
 
RESULTS 
Chikungunya virus up-regulates IFI16  
expression in multiple cell lines 
As we previously reported, the expression 
of endogenous IFI16 is up-regulated both at 
the mRNA level and protein level in human 
skin fibroblasts (HFF1) as assayed by qPCR 
Array and SILAC analysis, respectively 
(Wichit et al., 2017a, 2019). In the present 
study, we confirmed these data. As a matter 
of fact, Western blotting analysis against 
IFI16 was performed and we found an 
increase in the amount of IFI16 in CHIKV-
infected human fibroblasts in a time-
dependent manner (Figure 1A). In addition, 
we next extended our finding by detecting the 
expression of endogenous IFI16 in the human 
embryonic kidney cell line (HEK293T), a 
CHIKV permissive cell line (Krejbich-Trotot 
et al., 2011). To address this point, HEK293T 
cells were infected by CHIKV. The IFI16 
expression level was measured at 24 and 48 
hours after infection (hpi.). As observed with 
HFF1 cells, the mRNA as well as protein 
levels of IFI16 were up-regulated in a time-
dependent manner in HEK293T cells (Figure 
1B and 1C). The results indicated that 
intrinsic IFI16 responded to CHIKV infection 
indicating that it could play an important role 
in virus infection. In order to investigate 
effects of IFI16 on CHIKV and ZIKV 
infection, IFI16-overexpressed and silenced 
human skin fibroblasts were used as a model. 
 
Expression of IFI16 restricts Chikungunya 
virus infection 
Our previous study demonstrated the im-
mune sensor, AIM2, reduces CHIKV replica-
tion by the induction of the inflammasome in 
HFF1 cells (Ekchariyawat et al., 2015). Simi-
larly, IFI16, is an immune sensor that belongs 
to the HIN200 family similarly to AIM2. Both 
proteins were gathered in a new class of pat-
tern recognition receptors (PRRs) called 
AIM2-like receptors (ALRs) that can detect 
microbial DNA (Connolly and Bowie, 2014). 
Besides, several studies reported that IFI16 
can inhibit various types of DNA viruses 
(Broz and Monack, 2013). However, it is not 
known whether this inhibition may occur for 
 
 
Figure 1: CHIKV infection enhances IFI16 expression level in HFF1 and HEK293T. (A) HFF1 cells were either 
uninfected (Cont) or infected with CHIKV for 24 and 48 hpi. Then, infected cells were lysed for detection of IFI16 
and Actin by Western blotting analysis. HEK293T cells were either uninfected (Cont) or infected with CHIKV for 24 
and 48 hpi. (B) Infected cells were harvested either by Trizol for IFI16 mRNA quantification using qRT-PCR or (C) 
by lysis buffer for IFI16 and Actin detection using Western blotting analysis.
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RNA virus. Therefore, we examined the ef-
fects of IFI16 on CHIKV replication in HFF1 
cells. IFI16-overexpressing HFF1 cells were 
generated at the optimum concentration with-
out any cytotoxicity (Figure 2A). The protein 
expression level of IFI16 was confirmed by 
Western blot analysis (Figure 2B). Cells were 
subsequently infected with CHIKV at a MOI 
of 1 and the extent of virus replication was an-
alysed by quantifying the mRNA level and 
the number of virus particles. We found that 
both the viral RNA level and the virion pro-
duction of the virus were almost totally abro-
gated in infected fibroblasts that overex-
pressed IFI16 compared to the control condi-
tion after 24 and 48 hpi. (Figure 2C). To-
gether, these results revealed that forced ex-
pression of IFI16 could inhibit CHIKV repli-
cation, at least, in human skin cells. 
 
Depletion of IFI16 enhances Chikungunya 
virus infection 
In order to confirm the antiviral role of 
IFI16, we next investigated whether depletion 
of IFI16 had any impact on CHIKV replica-
tion. The expression of endogenous IFI16 was 
knocked down using a specific siRNA. The 
knockdown was confirmed by Western blot-
ting analysis (Figure 3A). Cells were then in-
fected by CHIKV for 24 and 48 h before 
quantification of the virus replication by qRT-
PCR and plaque assay. As expected, our re-
sults showed a significant increase of CHIKV 
viral mRNA and viral particle compared to 
control cells (Figure 3B and 3C). These data 
perfectly support an antiviral role of IFI16 in 
CHIKV infection by indicating that the 
expression level of IFI16 modulates viral 
replication. 
 
 
 
 
 
Figure 2: Overexpression of IFI16 in human skin fibroblasts inhibits CHIKV infection. HFF1 cells were transfected 
by either pControl or pIFI16 using lipofectamine 2000. After 24 and 48 h, transfected cells were (A) visually 
inspected to detect putative morphological changes and cell death, then, % viability was measured using a MTT 
assay. (B) IFI16 expression level was confirmed by Western blotting analysis. (C) IFI16 overexpressed cells were 
challenged with CHIKV for 24 and 48 h. Virus mRNA and virus particles were then quantified by qRT-PCR and 
plaque assay, repectively. Results are presented as mean ± SD from three independent experiments. % Reduction 
was calculated using the formular [1-(R/C)]*100 where C and R designate experimental values (RNA copy numbers 
or plaque numbers) in the presence of pCtrl and pIFI16, respectively. 
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Figure 3: Knockdown of IFI16 enhances CHIKV replication in human skin fibroblasts. HFF1 cells were transfected 
with either siControl or siRNA targeting IFI16 (siIFI16) using lipofectamine 2000. (A) The knockdown was confirmed 
by Western blotting analysis 24 h post transfection. (B) Cells were challenged with CHIKV for 24 and 48 h. The viral 
replication was quantified at the mRNA level by RT-qPCR and (C) number of virus particles were determined by 
plaque assay. The results are represented by mean ± SD of three independent experiments. **, p < 0.01, as com-
pared to siControl transfected cells. 
 
 
IFI16 suppressed the early stages, cell-to-
cell transmission and diffusion of the 
Chikungunya virus infection 
To further determine which step of the vi-
ral replication cycle is impacted by IFI16, 
cell-to-cell transmission and diffusion experi-
ments were carried out. IFI16-overexpressing 
vero cells or control cells were infected with 
CHIKV. 
Cells were fixed and stained by crystal violet 
to visualize the plaque formation. After 4 
days, expression of IFI16 in vero cells 
strongly suppressed the cytopathic effect 
(CPE) and plaque formation of virus infection 
(Figure 4). These results suggested that IFI16 
has an impact on the CHIKV replication cy-
cle, at least, in the early stage of the virus rep-
lication cycle. 
 
 
Figure 4: IFI16 restricts CHIKV infection in an early stage of infection. Vero cells were transfected by pIFI16 for 24 
h before being infected by CHIKV at MOIs of 0.1 and 1. Infected cells were fixed, stained and counted in order to 
quantify the number of virus particles. The results were represented as mean ± SD of three independent 
experiments. **, p < 0.01, as compared to pControl transfected cells. 
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IFI16 also exerts its antiviral activity 
against Zika virus infection 
Since the beginning of the 21st century, 
the emergence of CHIKV and ZIKV has 
taken place globally and is a major worldwide 
public health problem (Huang et al., 2019). In 
order to investigate whether the antiviral ef-
fects of IFI16 are limited only to CHIKV or 
may be extended to other viruses, we ex-
tended our experiment to determine a putative 
antiviral effect on ZIKV, a member of the ge-
nus Flavivirus, in human skin fibroblasts. 
Similarly to what was observed for CHIKV, 
IFI16 strongly inhibited the replication of 
ZIKV. RNA replication and virion production 
of virus were significantly inhibited and ap-
proached 100 %, without any deleterious ef-
fects on cell viability (Figure 5). Thus, our 
findings for a role of IFI16 in CHIKV are 
extendable to ZIKV. 
Figure 5: IFI16 exerts its antiviral activity to ZIKV 
infection in HFF1 cells. IFI16 overexpressing cells 
were challenged with ZIKV for 24 and 48 h. Virus 
mRNA and virus particle were then quantified by 
RT-qPCR and plaque assay, respectively. The 
results were represented mean ± SD of three 
independent experiments. % Reduction was 
calculated using the formular [1-(R/C)]*100 where 
C and R designate experimental values (RNA 
copy numbers or plaque numbers) in the pres-
ence of pCtrl and pIFI16, respectively. 
 
DISCUSSION 
CHIKV belongs to the alphavirus family 
transmitted by the Aedes spp. by the bite of 
human skin, a major cell type for viral entry. 
During infection, we have found that CHIKV-
infected human fibroblasts expressed a signif-
icantly increased level of various type I IFN-
responsive genes including the Interferon-γ-
inducible protein 16 (IFI16) (Wichit et al., 
2017a). In the same study, CHIKV infection 
in the presence of mosquito saliva markedly 
decreased IFI16 expression level resulting in 
the significant increase of viral transcripts and 
infectious viral particles. IFI16 was first re-
ported as a nuclear innate DNA sensor that 
can activate the inflammasome ultimately 
helping to fight infection (Kerur et al., 2011). 
Correlated with our finding, it was shown that 
the inflammasome signaling pathways exert 
antiviral effects against CHIKV via the acti-
vation of IL-1, maturation of caspase-1 and 
expression of the inflammasome sensor 
AIM2 (Ekchariyawat et al., 2015). These 
findings highlight a crucial role of IFI16 on 
CHIKV infection. Several groups proposed 
the antiviral activity of IFI16 against DNA vi-
rus infections such as adenovirus-based vec-
tor AdVIFI16, EBV, HCMV, HSV-1, HPV 
and retrovirus such as HIV-1 (Gariano et al., 
2012; Jakobsen et al., 2013; Lo Cigno et al., 
2015; Pisano et al., 2017; Johnson et al., 
2018). We extend herein these findings about 
the antiviral activity of IFI16 to arbovirus in-
fection. 
First, we confirmed our previous work 
which reported an up-regulation of IFI16 
mRNA level after CHIKV infection (Wichit 
et al., 2017a, 2019). We showed an up-regu-
lation of IFI16 protein after CHIKV infection 
in both human cutaneous fibroblast cell line 
(HFF1) and human embryonic kidney cells 
(HEK293T), which extended our previous 
findings. Indeed, it has been shown that IFI16 
expression could be induced by the vaccinia 
virus which is a DNA virus (Unterholzner et 
al., 2010). This similar finding may be ex-
plained by the ability of IFI16 to act as an im-
mune sensor for virus infection (Kerur et al., 
2011). We are the first group to report the in-
trinsic activation of IFI16 by CHIKV. 
Whether this up-regulation of IFI16 in in-
fected cells confers protection to hitherto un-
infected cells must be clarified in further ex-
periments. Secondly, the overexpression of 
IFI16 completely restricted CHIKV infection, 
and at least, cell-to-cell transmission and dif-
fusion. Therefore, it is likely that IFI16 up-
regulation could protect uninfected bystander 
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cells. In addition, our results appeared extend-
able to other arbovirus as we found IFI16 also 
exerted its antiviral activity against ZIKV in-
fection. These findings are strongly supported 
by the defection of type I IFN production 
which normally increases during CHIKV in-
fection to protect the cells. This was explained 
by the fact that IFI16 knockdown in cells may 
result in less recruitment of RNA polymerase 
II (Pol II) to the IFN- promoter leading to a 
defect in IFN- production and, result in re-
duced basal levels of ISGs (Thompson et al., 
2014). Recently, the reduction of RNA Pol II 
recruitment by IFI16 was proposed. IFI16 
forms nuclear filamentous structures called a 
“restrictosome” that appear to signal to prog-
eny viral genomes throughout the infected 
cell nucleus to cause their epigenetic silencing 
and reduce expression of the viral genes 
(Merkl and Knipe, 2019). 
 
CONCLUSION 
In conclusion, we provide the first report 
showing the crucial role of IFI16 antiviral ac-
tivity against members of arbovirus including 
CHIKV and ZIKV. Many mechanisms of 
IFI16-mediated virus suppression have been 
reported including an action as a restriction 
factor, as an interference of innate immune re-
sponses and as a filamentous nuclear assem-
bly, however, the antiviral mechanisms in-
volved in arbovirus infection remain unclear 
and require to be investigated in further stud-
ies. Although, more work is required, our 
study provides the novel potentially new host 
factor that can inhibit arbovirus infection, at 
least, in the early stages of infection. Thus our 
work paves the way to the development of 
novel antiviral strategies to fight arbovirus in-
fections in humans. 
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